Managing And Moving Your Advanced Therapeutic Product So You Can Focus On Your Path To Market

With the rapid advancements of mRNA therapeutics and continued interest, investment, and positive clinical progress in cell and gene therapies, the advanced therapeutics market is expected to outpace current capabilities. That’s why Thermo Fisher Scientific is continually investing in the capabilities and capacity needed to provide a solid infrastructure of supportive services. With offerings ranging from early kit production to customized packaging and labeling to secure storage, distribution, and logistics for patient samples, drugs, and critical drug substances, our end-to-end supply chain services can help de-risk nearly every part of your value chain.